0001104659-21-067336.txt : 20210517
0001104659-21-067336.hdr.sgml : 20210517
20210517070328
ACCESSION NUMBER: 0001104659-21-067336
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210513
FILED AS OF DATE: 20210517
DATE AS OF CHANGE: 20210517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax (China) IV L.P.
CENTRAL INDEX KEY: 0001726030
STATE OF INCORPORATION: E9
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31326
FILM NUMBER: 21927497
BUSINESS ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax (Cayman) IV L.P.
CENTRAL INDEX KEY: 0001726029
STATE OF INCORPORATION: E9
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31326
FILM NUMBER: 21927496
BUSINESS ADDRESS:
STREET 1: 4 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 4 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax IV GP L.P.
CENTRAL INDEX KEY: 0001726353
STATE OF INCORPORATION: L3
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31326
FILM NUMBER: 21927494
BUSINESS ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax (Israel) IV, L.P.
CENTRAL INDEX KEY: 0001726039
STATE OF INCORPORATION: E9
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31326
FILM NUMBER: 21927495
BUSINESS ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax Management 4 G.P. (2015) Ltd.
CENTRAL INDEX KEY: 0001726334
STATE OF INCORPORATION: L3
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31326
FILM NUMBER: 21927498
BUSINESS ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eloxx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001035354
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 841368850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (858) 909-0749
MAIL ADDRESS:
STREET 1: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Sevion Therapeutics, Inc.
DATE OF NAME CHANGE: 20140930
FORMER COMPANY:
FORMER CONFORMED NAME: SENESCO TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991006
FORMER COMPANY:
FORMER CONFORMED NAME: NAVA LEISURE USA INC
DATE OF NAME CHANGE: 19970310
4
1
tm2116620d3_4.xml
FORM 4
X0306
4
2021-05-13
0
0001035354
Eloxx Pharmaceuticals, Inc.
ELOX
0001726334
Pontifax Management 4 G.P. (2015) Ltd.
C/O ELOXX PHARMACEUTICALS, INC.
950 WINTER STREET
WALTHAM
MA
02451
0
0
1
0
0001726030
Pontifax (China) IV L.P.
C/O ELOXX PHARMACEUTICALS, INC.
950 WINTER STREET
WALTHAM
MA
02451
0
0
1
0
0001726029
Pontifax (Cayman) IV L.P.
C/O ELOXX PHARMACEUTICALS, INC.
950 WINTER STREET
WALTHAM
MA
02451
0
0
1
0
0001726039
Pontifax (Israel) IV, L.P.
C/O ELOXX PHARMACEUTICALS, INC.
950 WINTER STREET
WALTHAM
MA
02451
0
0
1
0
0001726353
Pontifax IV GP L.P.
C/O ELOXX PHARMACEUTICALS, INC.
950 WINTER STREET
WALTHAM
MA
02451
0
0
1
0
Common Stock
2021-05-13
4
P
0
1280624
1.35
A
1791470
I
By Pontifax Investment Fund
Common Stock
2021-05-13
4
P
0
2630487
1.35
A
3679797
I
By Pontifax Investment Fund
Common Stock
2021-05-13
4
P
0
1422222
1.35
A
1989551
I
By Pontifax Investment Fund
Common Stock
2021-05-13
4
P
0
592592
1.35
A
616592
I
By Pontifax Investment Fund
Reflects the purchase of shares in the offering of Common Stock of Eloxx Pharmaceuticals, Inc. that is expected to close on May 18, 2021.
Represents shares of the Issuer held by Pontifax (Cayman) IV L.P. ("Cayman IV"). Pontifax IV GP L.P. ("Pontifax IV") is the general partner of Cayman IV. Pontifax Management 4 G.P. (2015) Ltd. ("Management 4") is the general partner of Pontifax IV. As a result, each of Management 4 and Pontifax IV may be deemed to share voting and dispositive power with respect to the shares held by Cayman IV. Each of Management 4, Pontifax IV and Cayman IV disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
Represents shares of the Issuer held by Pontifax (Israel) IV, L.P. ("Israel IV"). Pontifax IV is the general partner of Israel IV. Management 4 is the general partner of Pontifax IV. As a result, each of Management 4 and Pontifax IV may be deemed to share voting and dispositive power with respect to the shares held by Israel IV. Each of Management 4, Pontifax IV and Israel IV disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
Represents shares of the Issuer held by Pontifax (China) IV L.P. ("China IV"). Pontifax IV is the general partner of China IV. Management 4 is the general partner of Pontifax IV. As a result, each of Management 4 and Pontifax IV may be deemed to share voting and dispositive power with respect to the shares held by China IV. Each of Management 4, Pontifax IV and China IV disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
Represents shares of the Issuer held by Pontifax Late Stage Fund L.P.("Late Stage Fund"). Pontifax Late Stage GP Ltd. ("Late Stage GP"), the general partner of Late Stage Fund, has a Strategic Alliance Agreement with Pontifax IV. By virtue of this relationship, Pontifax IV may be deemed to share voting and dispositive power with respect to the shares held by Late Stage Fund. Each of Management 4, Pontifax IV, Late Stage Fund and Late Stage GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
Pontifax Management 4 G.P. (2015) Ltd. /s/ Neil S. Belloff, Attorney-in-Fact on behalf of Tomer Kariv, Chief Executive Officer
2021-05-17
Pontifax (China) IV L.P. /s/ Neil S. Belloff, Attorney-in-Fact on behalf of Tomer Kariv, Chief Executive Officer
2021-05-17
Pontifax (Cayman) IV L.P. /s/ Neil S. Belloff, Attorney-in-Fact on behalf of Tomer Kariv, Chief Executive Officer
2021-05-17
Pontifax (Israel) IV, L.P. /s/ Neil S. Belloff, Attorney-in-Fact on behalf of Tomer Kariv, Chief Executive Officer
2021-05-17
Pontifax IV GP L.P. /s/ Neil S. Belloff, Attorney-in-Fact on behalf of Tomer Kariv, Chief Executive Officer
2021-05-17